Skip to content

Discontinued — last reported Q1 '24

Gross Profit at other companies

3M logo
3MMMM
$2.46B-0.8%
Danaher logo
DanaherDHR
$3.59B+2.3%
STERIS logo
STERISSTE
$697.2M+8.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Fortive logo
FortiveFTV
$675.5M+6.0%
Personalis, Inc. logo
Personalis, Inc.PSNL
$281K-96.1%

Segments

By segment

See full
Clinical Genomics$7.39M+16.9%
Biopharmaceutical Development$5.2M-28.3%

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Calculated from Mesa Laboratories’s reported figures.

The official record: Mesa Laboratories’s 10-Q, filed August 3, 2023, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's gross profit?
Mesa Laboratories (MLAB) reported gross profit of $31.18M in Q2 2023.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.